{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:50:13Z","timestamp":1791237013992,"version":"4.1.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,5]],"date-time":"2014-03-05T00:00:00Z","timestamp":1393977600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0090569","type":"journal-article","created":{"date-parts":[[2014,3,5]],"date-time":"2014-03-05T21:35:39Z","timestamp":1394055339000},"page":"e90569","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":98,"title":["Correlation between Genotypic and Phenotypic Testing for Resistance to Rifampin in Mycobacterium tuberculosis Clinical Isolates in Haiti: Investigation of Cases with Discrepant Susceptibility Results"],"prefix":"10.1371","volume":"9","author":[{"given":"Oksana","family":"Ocheretina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent E.","family":"Escuyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Marcelle","family":"Mabou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertrude","family":"Royal-Mardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stalz C.","family":"Vilbrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean W.","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,5]]},"reference":[{"key":"ref1","unstructured":"Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB): Policy Statement. Geneva, World Health Organization, 27 June 2008; Available: http:\/\/www.who.int\/tb\/features_archive\/policy_statement.pdf<\/ext-link>. Accessed7 February 2014."},{"key":"ref2","unstructured":"Rapid implementation of the Xpert MTB\/RIF diagnostic test. WHO\/HTM\/TB\/2011.2. Geneva, World Health Organization, 2011. Available: http:\/\/whqlibdoc.who.int\/publications\/2011\/9789241501569_eng.pdf<\/ext-link>. Accessed 7 February 2014."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1054\/tuld.1998.0002","article-title":"Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis<\/italic>: 1998 update","volume":"79(1)","author":"S Ramaswamy","year":"1998","journal-title":"Tuber Lung Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0140-6736(93)90417-F","article-title":"Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis<\/italic>","volume":"341","author":"A Telenti","year":"1993","journal-title":"Lancet"},{"key":"ref5","unstructured":"Guidelines for surveillance of drug resistance in tuberculosis. Geneva, World Health Organization, 1994, (document WHO\/TB\/94.178). Available: http:\/\/who.int\/tb\/publications\/1994\/en\/index.html<\/ext-link>. Accessed7 February 2014."},{"key":"ref6","first-page":"481","article-title":"Detection of rifampicin resistance in Mycobacterium tuberculosis<\/italic> isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance","volume":"4(5)","author":"H Traore","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref7","unstructured":"World Health Organization. Global tuberculosis control: 2011. Geneva: WHO; Available from: http:\/\/www.who.int\/tb\/publications\/global_report\/2011\/gtbr11_<\/ext-link> full.pdf. Accessed7 February 2014."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1590\/S1020-49892012000300006","article-title":"Multidrug- resistant tuberculosis in Port-au-Prince,","volume":"31","author":"O Ocheretina","year":"2012","journal-title":"Haiti. Rev. Panam. Salud Publica"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","article-title":"Rapid molecular detection of tuberculosis and rifampin resistance","volume":"363(11)","author":"CC Boehme","year":"2010","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e1001067","DOI":"10.1371\/journal.pmed.1001067","article-title":"Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB\/RIF assay: a prospective study","volume":"8(7)","author":"SD Lawn","year":"2011","journal-title":"PLoS Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1128\/JCM.00268-13","article-title":"Use of Luminex MagPlex Magnetic Microspheres for High-Throughput Spoligotyping of Mycobacterium tuberculosis<\/italic> Isolates in Port-au-Prince, Haiti","volume":"51(7)","author":"O Ocheretina","year":"2013","journal-title":"J Clin Microbiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1128\/JCM.35.4.907-914.1997","article-title":"Simultaneous detection and strain differentiation of Mycobacterium tuberculosis<\/italic> for diagnosis and epidemiology","volume":"35(4)","author":"J Kamerbeek","year":"1997","journal-title":"J Clin Microbiol"},{"key":"ref13","unstructured":"Kent PT, Kubica GP. (1985) Public health mycobacteriology: a guide for the level III laboratory. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, USA."},{"key":"ref14","unstructured":"National Committee on Clinical Laboratory Standards. Susceptibility testing of Mycobacteria, Nocardiae, and other aerobic Actinomycetes. Approved standard. NCCLS document M24-A. Wayne, Pennsylvania: NCCLS; 2003."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/JCM.36.2.362-366.1998","article-title":"Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis<\/italic> isolates by using the microplate Alamar Blue assay","volume":"36(2)","author":"SG Franzblau","year":"1998","journal-title":"J Clin Microbiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1128\/JCM.01209-09","article-title":"Mycobacterium tuberculosis<\/italic> strains with highly discordant rifampin susceptibility test results","volume":"47(11)","author":"A Van Deun","year":"2009","journal-title":"J Clin Microbiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","article-title":"Feasibility, diagnostic accuracy, and effectiveness of decentralized use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study","volume":"377(9776)","author":"CC Boehme","year":"2011","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1128\/JCM.02499-08","article-title":"Performance assessment of the GenoType MTBDRplus test and DNA sequencing in detection of multidrug-resistant Mycobacterium tuberculosis<\/italic>","volume":"47(8)","author":"WL Huang","year":"2009","journal-title":"J Clin Microbiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.201101-0056OC","article-title":"Evaluation of the Xpert MTB\/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting","volume":"184(1)","author":"G Theron","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1128\/JCM.02214-10","article-title":"Evaluation of the Cepheid Xpert MTB\/RIF assay for direct detection of Mycobacterium tuberculosis<\/italic> complex in respiratory specimens","volume":"49(4)","author":"EM Marlowe","year":"2011","journal-title":"J Clin Microbiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5588\/ijtld.11.0395","article-title":"False-positive rifampicin resistance on Xpert\u00ae MTB\/RIF: case report and clinical implications","volume":"16(2)","author":"A Van Rie","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/jac\/42.5.621","article-title":"Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB<\/italic> mutations of Mycobacterium tuberculosis<\/italic>","volume":"42(5)","author":"B Yang","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/sj.emboj.7600499","article-title":"Structural, functional, and genetic analysis of sorangicin inhibition of bacterial RNA polymerase","volume":"24(4)","author":"EA Campbell","year":"2005","journal-title":"EMBO J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1128\/JCM.06479-11","article-title":"Performance of Tuberculosis Drug Susceptibility Testing in the United States Laboratories from 1994-2008","volume":"50(4)","author":"PK Angra","year":"2012","journal-title":"J Clin Microbiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/JCM.31.4.767-770.1993","article-title":"The resurgence of tuberculosis: is your laboratory ready?","volume":"31(4)","author":"FC Tenover","year":"1993","journal-title":"J Clin Microbiol"},{"key":"ref26","first-page":"216","article-title":"Clinical failures associated with rpoB<\/italic> mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis<\/italic>","volume":"16(2)","author":"DA Williamson","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng.1038","article-title":"Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis<\/italic> strains identifies compensatory mutations in RNA polymerase genes","volume":"44(1)","author":"I Comas","year":"2011","journal-title":"Nat Genet"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1128\/JCM.35.2.492-494.1997","article-title":"Mutations in the rpoB<\/italic> gene of Mycobacterium tuberculosis<\/italic> that interfere with PCR-single-strand conformation polymorphism analysis for rifampin susceptibility testing","volume":"35(2)","author":"BJ Kim","year":"1997","journal-title":"J Clin Microbiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1128\/JCM.06860-11","article-title":"Molecular characterization of multidrug- and extensively drug-resistant Mycobacterium tuberculosis<\/italic> strains in Jiangxi, China","volume":"50(7)","author":"X Yuan","year":"2012","journal-title":"J Clin Microbiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1128\/JCM.39.8.2987-2990.2001","article-title":"Mutations in the rpoB<\/italic> gene of multidrug-resistant Mycobacterium tuberculosis<\/italic> clinical isolates from India","volume":"39(8)","author":"C Mani","year":"2001","journal-title":"J Clin Microbiol"},{"key":"ref31","first-page":"207","article-title":"An evaluation of the Xpert MTB\/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis","volume":"74(2)","author":"DA Williamson","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1128\/JCM.32.4.1095-1098.1994","article-title":"Characterization by automated DNA sequencing of mutations in the gene (rpoB<\/italic>) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis<\/italic> strains from New York City and Texas","volume":"32(4)","author":"V Kapur","year":"1994","journal-title":"J Clin Microbiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1128\/JCM.00659-11","article-title":"Isolation of Mycobacterium tuberculosis<\/italic> strains with a silent mutation in rpoB<\/italic> leading to potential misassignment of resistance category","volume":"49(7)","author":"M Alonso","year":"2011","journal-title":"J Clin Microbiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1128\/JCM.05314-11","article-title":"Silent mutation in rpoB<\/italic> detected from clinical samples with rifampin-susceptible Mycobacterium tuberculosis<\/italic>","volume":"49(10)","author":"R Moure","year":"2011","journal-title":"J Clin Microbiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e1001061","DOI":"10.1371\/journal.pmed.1001061","article-title":"Comparison of Xpert MTB\/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study","volume":"8(7)","author":"LE Scott","year":"2011","journal-title":"PLoS Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1183\/09031936.00061808","article-title":"GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis","volume":"32","author":"DI Ling","year":"2008","journal-title":"Eur. Respir. J"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1128\/CMR.00047-06","article-title":"Setting and revising antibacterial susceptibility breakpoints","volume":"20(3)","author":"J Turnidge","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s15010-009-7108-9","article-title":"A long journey from minimum inhibitory concentration testing to clinically predictive breakpoints: deterministic and probabilistic approaches in deriving breakpoints","volume":"37(4)","author":"A Dalhoff","year":"2009","journal-title":"Infection"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1128\/AAC.01474-09","article-title":"New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic\/pharmacodynamic science and population pharmacokinetic variability","volume":"54(4)","author":"T Gumbo","year":"2010","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0090569","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T01:40:58Z","timestamp":1597542058000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0090569"}},"subtitle":[],"editor":[{"given":"Igor","family":"Mokrousov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,5]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0090569","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,5]]}}}